디알
디알젬 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 박정병, was filed 21 Nov 2024.
디알젬: what insiders have been doing
This page follows insider dealings at 디알젬 as filed with DART (FSS), a company from the Health Care sector. Nothing new has been filed by managers of 디알젬 in twelve months, the latest record being from 21 November 2024.
In the same sector, recent insider purchases at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. also feature in our signals. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Insider Decl.
7
Thresholds
n/a
Buy Volume
n/a
4 ops. · all time
Sell Volume
n/a
3 ops. · all time
Financial data
· cache
Last declaration on 21 November 2024
Declarations7 total
- 361 sharesKRXDART:20241121000476Canonical exit: 13 Feb 2025 (T+90)
- ShareKRXDART:20220811000246
- 361 sharesKRXDART:20220811000244Canonical exit: 9 Nov 2022 (T+90)
- ShareKRXDART:20220718000088
- 361 sharesKRXDART:20220718000086Canonical exit: 16 Oct 2022 (T+90)
- 361 sharesKRXDART:20220603000128Canonical exit: 1 Sept 2022 (T+90)
- ShareKRXDART:20220603000118
7 of 7 declarations
About 디알젬
디알젬 is a company listed on the XKRX market, specializing in the healthcare and pharmaceutical sector. It focuses on the development and commercialization of innovative pharmaceutical products.
